Edition:
United Kingdom

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

40.79USD
7:50pm BST
Change (% chg)

$0.38 (+0.94%)
Prev Close
$40.41
Open
$40.62
Day's High
$40.99
Day's Low
$40.44
Volume
32,677
Avg. Vol
343,765
52-wk High
$47.86
52-wk Low
$33.77

Latest Key Developments (Source: Significant Developments)

Catalent Announces Public Offering Of 9.94 Mln Common Shares Priced At $40.24 Per Share
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Catalent Inc ::CATALENT, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING OF 9.94 MILLION COMMON SHARES PRICED AT $40.24PER SHARE.  Full Article

Catalent Announces Public Offering Of Common Stock
Monday, 23 Jul 2018 

July 23 (Reuters) - Catalent Inc ::CATALENT, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK.CATALENT INC - ANNOUNCED THAT IT HAS LAUNCHED AN UNDERWRITTEN PUBLIC OFFERING OF $400.0 MILLION OF ITS COMMON STOCK.CATALENT INC - INTENDS TO USE NET PROCEEDS OF OFFERING TO REPAY A PORTION OF OUTSTANDING BORROWINGS UNDER ITS U.S. DOLLAR-DENOMINATED TERM LOANS.  Full Article

Juniper Pharma To Pay Catalent Termination Fee Of $5.58 Mln Under Certain Circumstances
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Catalent Inc ::JUNIPER PHARMACEUTICALS SAYS UPON TERMINATION OF MERGER UNDER CERTAIN CIRCUMSTANCES, CO TO PAY CATALENT TERMINATION FEE OF $5.580 MILLION - SEC FILING.  Full Article

Juniper Pharmaceuticals Says Signs Definitive Agreement To Be Acquired By Catalent For $11.50 Per Share In Cash
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Juniper Pharmaceuticals Inc ::JUNIPER PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED BY CATALENT, INC. FOR $11.50 PER SHARE IN CASH.JUNIPER PHARMACEUTICALS - DEFINITIVE AGREEMENT WITH CATALENT FOR CATALENT TO BUY ALL OF OUTSTANDING SHARES OF CO AT $11.50 PER SHARE IN CASH.TRANSACTION REPRESENTS A TOTAL EQUITY VALUE OF APPROXIMATELY $139.6 MILLION ON A FULLY-DILUTED BASIS.TRANSACTION APPROVED UNANIMOUSLY BY JUNIPER BOARD OF DIRECTORS.ROTHSCHILD & CO IS ACTING AS FINANCIAL ADVISOR AND GOODWIN PROCTER LLP IS ACTING AS LEGAL COUNSEL TO JUNIPER.  Full Article

Catalent Signs Agreement To Acquire Juniper Pharmaceuticals
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Catalent Inc ::CATALENT SIGNS AGREEMENT TO ACQUIRE JUNIPER PHARMACEUTICALS, INC..CATALENT INC -UNDER ACQUISITION AGREEMENT WITH JUNIPER, CO'S SUBSIDIARY TO COMMENCE TENDER OFFER TO PURCHASE ALL OF JUNIPER'S SHARES FOR PRICE OF $11.50.CATALENT INC SAYS CATALENT WILL CONTINUE TO SUPPORT JUNIPER'S CRINONE FRANCHISE MARKETED BY MERCK KGAA OUTSIDE OF U.S..CATALENT INC-AFTER TENDER OFFER, CO INTENDS TO COMPLETE DEAL BY BUYING REMAINDER JUNIPER SHARES AT SAME PRICE THROUGH MERGER WITH NEWLY FORMED UNIT OF CO.  Full Article

Catalent Q1 earnings per share $0.03
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Catalent Inc ::Catalent Inc. Reports first quarter fiscal 2018 results.Q1 earnings per share $0.03.Sees FY 2018 revenue $2.31 billion to $2.41 billion.Q1 revenue $543.9 million versus I/B/E/S view $491 million.Q1 earnings per share view $0.17 -- Thomson Reuters I/B/E/S.Q1 adjusted non-gaap earnings per share $0.21.Catalent - ‍expects fiscal year 2018 adjusted EBITDA in range of $521 million to $547 million and adjusted net income in range of $198 million to $224 million​.Catalent - ‍company expects self-funded capital expenditures in range of $152 million to $165 million for FY2018 ​.Catalent - ‍expects self-funded capital expenditures in range of $152 million to $165 million for fiscal year 2018​.Fy2018 revenue view $2.31 billion -- Thomson Reuters I/B/E/S.  Full Article

Catalent announces pricing of private offering of senior unsecured notes due 2026
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Catalent Inc :Catalent announces pricing of private offering of senior unsecured notes due 2026.Catalent Inc - unit ‍priced a private offering of $450.0 million in aggregate principal amount of 4.875 percent senior unsecured notes due 2026 at par​.  Full Article

Catalent launches private offering of $450 mln of senior unsecured notes due 2026
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Catalent Inc ::Catalent announces launch of private offering of $450 million of senior unsecured notes due 2026.Catalent - intends to use net proceeds from private offering to fund, in part, purchase price of previously announced pending deal of Cook Pharmica ​.  Full Article

Catalent Inc announces pricing of public offering
Wednesday, 27 Sep 2017 

Sept 26 (Reuters) - Catalent Inc :Catalent Inc announces pricing of public offering of common stock to fund part of its acquisition of Cook Pharmica.Announced pricing of an underwritten public offering of 6.4 million shares of its common stock at a price to public of $39.10 per share.  Full Article

Catalent announces secondary offering of about 19 mln shares of co's common stock
Tuesday, 6 Sep 2016 

Catalent, inc. : Announces secondary public offering of common stock .Says secondary offering of about 19.0 million shares of Catalent's common stock.  Full Article

Deals of the day-Mergers and acquisitions

July 3 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday: